相关实验视频

Updated: May 12, 2026

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

8.6K

评估最小残留疾病负面性作为多发性骨髓瘤治疗有效性的替代终点:随机对照试验的元分析

Ioannis Ntanasis-Stathopoulos1, Charalampos Filippatos1, Anastasios Ntanasis-Stathopoulos1

  • 1Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.

American journal of hematology
|January 9, 2025
PubMed
概括

实现最小残留疾病 (MRD) 负面性显著改善了多发性骨髓瘤 (MM) 患者的生存结果. 这一元分析证实MRD阴性是MM中长期无进展和整体存活的强有力的预测因素.

关键词:
终点终点终点是一个终点.最少残留疾病的最小残留疾病.多发性骨髓瘤是多发性骨髓瘤的一种.总体存活率 总体存活率没有进展的生存率.

更多相关视频

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia09:57

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on: March 5, 2018

29.2K
Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer08:12

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer

Published on: March 14, 2019

5.4K

相关概念视频

Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...